509 related articles for article (PubMed ID: 32721809)
41. Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.
Wang C; Wang S; Li D; Wei DQ; Zhao J; Wang J
Gastroenterology; 2020 Sep; 159(3):1145-1147.e4. PubMed ID: 32437749
[No Abstract] [Full Text] [Related]
42. Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor
Nowak JK; Lindstrøm JC; Kalla R; Ricanek P; Halfvarson J; Satsangi J
Gastroenterology; 2020 Sep; 159(3):1151-1154.e2. PubMed ID: 32413354
[No Abstract] [Full Text] [Related]
43. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.
Novelli A; Biancolella M; Borgiani P; Cocciadiferro D; Colona VL; D'Apice MR; Rogliani P; Zaffina S; Leonardis F; Campana A; Raponi M; Andreoni M; Grelli S; Novelli G
Hum Genomics; 2020 Sep; 14(1):29. PubMed ID: 32917283
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
Tan HW; Xu YM; Lau ATY
Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627
[TBL] [Abstract][Full Text] [Related]
45. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
46. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
47. Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects.
Acheampong DO; Barffour IK; Boye A; Aninagyei E; Ocansey S; Morna MT
Biomed Pharmacother; 2020 Nov; 131():110748. PubMed ID: 33152916
[TBL] [Abstract][Full Text] [Related]
48. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
[TBL] [Abstract][Full Text] [Related]
49. Kawasaki disease epidemic: pitfalls.
Gallizzi R; Corsello G; Pajno GB
Ital J Pediatr; 2020 Aug; 46(1):121. PubMed ID: 32854742
[TBL] [Abstract][Full Text] [Related]
50. An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise?
Cavallo F; Chiarelli F
Acta Biomed; 2020 Sep; 91(3):e2020015. PubMed ID: 32921711
[TBL] [Abstract][Full Text] [Related]
51. The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
Abassi Z; Knaney Y; Karram T; Heyman SN
Front Immunol; 2020; 11():1312. PubMed ID: 32582222
[TBL] [Abstract][Full Text] [Related]
52. COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?
Kutti Sridharan G; Kotagiri R; Chandiramani VH; Mohan BP; Vegunta R; Vegunta R; Rokkam VRP
Am J Ther; 2020; 27(4):e400-e402. PubMed ID: 32366740
[TBL] [Abstract][Full Text] [Related]
53. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection.
Liu F; Long X; Zhang B; Zhang W; Chen X; Zhang Z
Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2128-2130.e2. PubMed ID: 32334082
[TBL] [Abstract][Full Text] [Related]
54. Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications.
Revzin MV; Raza S; Warshawsky R; D'Agostino C; Srivastava NC; Bader AS; Malhotra A; Patel RD; Chen K; Kyriakakos C; Pellerito JS
Radiographics; 2020 Oct; 40(6):1574-1599. PubMed ID: 33001783
[TBL] [Abstract][Full Text] [Related]
55. Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.
Barillà F; Bassareo PP; Calcaterra G; Romeo F; Mehta JL
J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):630-633. PubMed ID: 32740495
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
Mjaess G; Karam A; Aoun F; Albisinni S; Roumeguère T
Prog Urol; 2020 Sep; 30(10):484-487. PubMed ID: 32620366
[TBL] [Abstract][Full Text] [Related]
57. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
Xu J; Xu X; Jiang L; Dua K; Hansbro PM; Liu G
Respir Res; 2020 Jul; 21(1):182. PubMed ID: 32664949
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019.
Zheng H; Cao JJ
Am J Pathol; 2020 Oct; 190(10):2013-2017. PubMed ID: 32735889
[TBL] [Abstract][Full Text] [Related]
59. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.
Anand SP; Chen Y; Prévost J; Gasser R; Beaudoin-Bussières G; Abrams CF; Pazgier M; Finzi A
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003587
[TBL] [Abstract][Full Text] [Related]
60. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
